Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

Lämmer, Johannes; Malagari, Katarina; J. Vogl, Thomas; Pilleul, F.; Denys, Alban; Watkinson, A.; B. Pitton, Michael; Sergent, Géraldine; Pfammatter, Thomas; Terraz, Sylvain; Benhamou, Yves; Avajon, Yves; Gruenberger, Thomas; Pomoni, Maria; Langenberger, Herbert; Schuchmann, M.; Dumortier, Jérôme; Mueller, Christian; Chevallier, P.; Lencioni, Riccardo; Behalf of the PRECISION V Investigators, On

doi:10.1007/s00270-009-9711-7

Public

Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

Published in CardioVascular and Interventional Radiology • Nov 11, 2009

Authors:

Johannes Lämmer

Katarina Malagari

Thomas J. Vogl

Abstract

Transcatheter arterial chemoembolization (TACE) offers a survival benefit to patients with intermediate hepatocellular carcinoma (HCC). A widely accepted TACE regimen includes administration of doxorubicin-oil emulsion followed by gelatine sponge-conventional TACE. Recently, a drug-eluting bead (DC ...

Subject

Medicine

Hepatocellular carcinoma

Doxorubicin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!